A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

The drug, known as suzetrigine, is the first new painkiller approved in the U.S. since 1998. It can be used to relieve pain after surgery or injury, and some researchers say it might be the start of a ...

Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...

Medicare agency unveils 15 drugs subject to price negotiations Drug industry renews concerns with drug selection process The Biden administration’s selection of 15 new drugs for price negotiations is ...

The states want the federal Food and Drug Administration to prohibit telehealth prescriptions for mifepristone and require that it be used only in the first seven weeks of pregnancy instead of the ...

Combination birth control pills, or the pill for short, are oral contraceptives that prevent pregnancy. If you’re considering your birth control options, the pill is one of the most common and ...

Took your pill late and wondering whether it’s safe to have sex with your partner? We got you. Minipill: Follow the same instructions as if you took your last pill less than 24 hours ago (in the ...

These pills are formulated to upgrade multiple elements of males’ sexual wellness, such as amplifying libido, bettering erectile function, and enhancing stamina. When it comes to male ...

CATCH BURNSIDE AND ARRESTED HIM. NEW TONIGHT AN 18 YEAR OLD HIGH SCHOOL DROPOUT ON THE TREASURE COAST IS FACING DRUG RELATED CHARGES AFTER THE MARTIN COUNTY SHERIFF SAYS HE WAS IN POSSESSION OF MDMA.